Clinical trial
Evaluation of Efficacy of Ophthalmic Solution in Seasonal Allergic…
NCT00364091 · Vistakon Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00364091 |
|---|---|
| Title | Evaluation of Efficacy of Ophthalmic Solution in Seasonal Allergic Conjunctivitis |
| Official title | A Multi-Center, Randomized, Double-Masked Parallel Group Study Evaluating the Efficacy, Safety, and QOL of R89674 0.25% Ophthalmic Solution Compared to Vehicle or an Active Control in a Modified Model of Environmental Seasonal Allergic Conjunctivitis |
| Lead sponsor | Vistakon Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Allergic Conjunctivitis |
| Intervention type | Drug |
| Interventions | R89674 0.025% ophthalmic solution |
| Enrollment | 365 |
| Start date | Aug 1, 2006 |
| Primary completion | Oct 1, 2006 |
| First posted | Aug 15, 2006 |
| Last update posted | Sep 27, 2011 |
| Countries | United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: